Literature DB >> 6541221

Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor.

C Heussen, F Joubert, E B Dowdle.   

Abstract

Seeds of the legume Erythrina latissima contain a 20,000-dalton, single-chain protein that has been shown to inhibit the amidolytic activity of trypsin and tissue plasminogen activator. It had no comparable effect on urokinase. IC50 values of 1.1 X 10(-7) M for tissue plasminogen activator and 6.9 X 10(-10) M for trypsin were determined by titration. When coupled to agarose, the Erythrina inhibitor provided an effective reagent for affinity purification of tissue plasminogen activator from melanoma cell-conditioned tissue culture medium. Using this as a single-step procedure, 270-fold purified enzyme was reproducibly obtained with yields of 90% or greater. Both one- and two-chain forms of tissue plasminogen activator were purified. The enzyme migrated, in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, as a predominant 72,000-dalton doublet with lesser amounts of immunochemically similar, 115,000- and 68,000-dalton components.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6541221

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Crystallization and preliminary X-ray analysis of a protease inhibitor from the latex of Carica papaya.

Authors:  Mohamed Azarkan; Abel Garcia-Pino; Rachid Dibiani; Lode Wyns; Remy Loris; Danielle Baeyens-Volant
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-11-30

2.  Secretion of active recombinant human tissue plasminogen activator derivatives in Escherichia coli.

Authors:  J Manosroi; C Tayapiwatana; F Götz; R G Werner; A Manosroi
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792

3.  Role of P225 and the C136-C201 disulfide bond in tissue plasminogen activator.

Authors:  A Vindigni; E Di Cera
Journal:  Protein Sci       Date:  1998-08       Impact factor: 6.725

4.  Performance characteristics of mammalian cell culture process operating continuously with protein-free medium.

Authors:  R Bliem; R Oakley; K Matsuoka; V Taiariol
Journal:  Appl Biochem Biotechnol       Date:  1990-12       Impact factor: 2.926

5.  Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis.

Authors:  Sergei Zaitsev; Sergei Zaitzev; Dirk Spitzer; Juan-Carlos Murciano; Bi-Sen Ding; Samira Tliba; M Anna Kowalska; Khalil Bdeir; Alice Kuo; Victoria Stepanova; John P Atkinson; Mortimer Poncz; Douglas B Cines; Vladimir R Muzykantov
Journal:  J Pharmacol Exp Ther       Date:  2009-12-01       Impact factor: 4.030

6.  Expression of active human tissue-type plasminogen activator in Escherichia coli.

Authors:  J Qiu; J R Swartz; G Georgiou
Journal:  Appl Environ Microbiol       Date:  1998-12       Impact factor: 4.792

7.  Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.

Authors:  J H Verheijen; M P Caspers; G T Chang; G A de Munk; P H Pouwels; B E Enger-Valk
Journal:  EMBO J       Date:  1986-12-20       Impact factor: 11.598

8.  In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.

Authors:  P Mignatti; R Tsuboi; E Robbins; D B Rifkin
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.